|Videos|November 18, 2016

What Are the Downsides to Taking Antibiotics?

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, warns of the potential downsides to taking antibiotics.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, warns of the potential downsides of taking antibiotics.

Interview Transcript (slightly modified for readability)

“We know that antibiotics only work to treat bacterial infections and there are certain bacterial infections, like pneumonia, that really require antibiotic treatment, [and] urinary tract infections, that require treatment. What [antibiotics] don’t treat are a lot of the common infections that are nagging, annoying infections that we encounter this time of year. So, the colds, the coughs, the aches, even influenza, or flu, [are] caused by a virus, and in those circumstances, antibiotics just don’t help at all and could, potentially, cause more harm than good.

The other point is that we want to make sure that when we’re taking antibiotics, [that] we really need them. Because each and every time we take an antibiotic, it changes the bacteria that live in and on our bodies. So, not only does that put us at an increased risk for a potential future antibiotic-resistant infection, but we’re learning more and more about the impact of antibiotics on the good bacteria that live in our gut, that we rely upon for our own health. We’re concerned that there are potential downstream effects of taking an antibiotic, especially when it’s not needed.”


Related to this article

This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.